In “secondary” tauopathies such as Alzheimer's disease (AD), Lewy body dementia (LBD), Parkinson's disease (PD), and Down syndrome,1, 2 tau pathology develops alongside other pathologic proteins. This evidence concerns the gene MAPT and Parkinson disease.